Biosimilars - A Major Future Market

biosimilars_detail.jpeg

Sandoz is the pioneer and undisputed global leader in the rapidly emerging market for biosimilars, also known as follow-on biologics (or biopharmaceuticals).

In 2010, the US Congress established for the first time a regulatory pathway for the approval of biosimilars. Sandoz already brings affordable, high-quality biosimilars like Omnitrope®, Binocrit® and Zarzio® to patients in many markets around the world, providing greater access to these state-of-the-art treatments.

Visit our stand-alone Sandoz Biosimilars Website to find out more about why biologics matter, how biosimilars are broadening access to these essential medicines, and why Sandoz is leading the way.

New research highlights need for a competitive functioning biologics market to achieve full potential of biosimilars

bio.jpg

Select a category

Related content

Biosimilars or Follow-On Biologics

teaser_biosimilars.jpg

Sandoz is the pioneer and undisputed global leader in the rapidly emerging market for biosimilars, also known as follow-on biologics (or biopharmaceuticals).

FAQs

teaser_faq.jpg

 

Want to know more about our products?